Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

196 Press Releases
DateTitleCompany
10 Apr 14 Biogen Idec Names Adam M. Koppel as SVP and Chief Strategy Officer Biogen Idec,
Published by
Business Wire
31 Mar 14 Biogen Idec to Report First Quarter 2014 Financial Results on April 23, 2014 Biogen Idec Inc.,
Published by
Business Wire
18 Mar 14 Biogen Idec Receives Notification of PDUFA Date Extension for Plegridy™ (Peginterferon Beta-1a) Biogen Idec,
Published by
Business Wire
25 Feb 14 Biogen Idec to Present at the Cowen & Company 34th Annual Health Care Conference Biogen Idec Inc.,
Published by
Business Wire
18 Feb 14 Biogen Idec to Present at the 2014 RBC Capital Markets’ Healthcare Conference Biogen Idec Inc.,
Published by
Business Wire
15 Feb 14 William D. Young To Retire From Biogen Idec’s Board of Directors Biogen Idec,
Published by
Business Wire
15 Jan 14 Biogen Idec to Report Fourth Quarter and Year-End 2013 Financial Results on January 29, 2014 Biogen Idec Inc.,
Published by
Business Wire
15 Jan 14 Biogen Idec Announces Availability of FAMPYRA® in Ireland to Treat Walking Impairment in Adults with Multiple Sclerosis Biogen Idec,
Published by
Business Wire
08 Jan 14 Biogen Idec to Present at the 32nd Annual J.P. Morgan Healthcare Conference Biogen Idec Inc.,
Published by
Business Wire
17 Dec 13 Biogen Idec and Samsung Bioepis Announce Agreement to Market Anti-TNF Biosimilar Product Candidates in Europe Biogen Idec,
Published by
Business Wire
11 Dec 13 Biogen Idec Foundation in Collaboration with Cambridge Community Foundation Awards Grants in Science Education Biogen Idec Foundation,
Published by
Business Wire
02 Dec 13 Biogen Idec Receives Notification from FDA of PDUFA Date Extension for ALPROLIX™ Biogen Idec,
Published by
Business Wire
26 Nov 13 Biogen Idec to Present at the 2013 Deutsche Bank BioFEST Biogen Idec Inc.,
Published by
Business Wire
22 Nov 13 CHMP Determines Dimethyl Fumarate in TECFIDERA® to be a New Active Substance in the European Union Biogen Idec,
Published by
Business Wire
05 Nov 13 Biogen Idec to Present at the Credit Suisse Healthcare Conference Biogen Idec Inc.,
Published by
Business Wire
07 Oct 13 Biogen Idec to Report Third Quarter 2013 Financial Results on October 28, 2013 Biogen Idec Inc.,
Published by
Business Wire
24 Sep 13 Biogen Idec Becomes First U.S.-Based Biotech Named to Dow Jones Sustainability World Index Biogen Idec,
Published by
Business Wire
20 Sep 13 Biogen Idec Employees Participate in Third Annual “Care Deeply Volunteer Day” Biogen Idec,
Published by
Business Wire
04 Sep 13 Biogen Idec Foundation Awards $250,000 Grant to Citizen Schools to Invest in Science Education in Massachusetts and North Carolina Biogen Idec,
Published by
Business Wire
03 Sep 13 Biogen Idec to Present at the Stifel Nicolaus 2013 Global Healthcare Conference Biogen Idec Inc.,
Published by
Business Wire
29 Aug 13 Biogen Idec to Present at the Morgan Stanley Global Healthcare Conference Biogen Idec Inc.,
Published by
Business Wire
19 Jul 13 US and EU Regulatory Authorities Accept PLEGRIDY™ (peginterferon beta-1a) Marketing Applications for Review Biogen Idec,
Published by
Business Wire
03 Jul 13 Biogen Idec to Report Second Quarter 2013 Financial Results on July 25, 2013 Biogen Idec Inc.,
Published by
Business Wire
05 Jun 13 Biogen Idec 2013 Annual Shareholder Meeting Webcast Biogen Idec Inc.,
Published by
Business Wire
28 May 13 Biogen Idec to Present at the Jefferies 2013 Global Healthcare Conference Biogen Idec Inc.,
Published by
Business Wire
24 May 13 Biogen Idec Appoints Spyros Artavanis-Tsakonas Chief Scientific Officer Biogen Idec,
Published by
Business Wire
24 May 13 Biogen Idec to Present at the Deutsche Bank 38th Annual dbAccess Healthcare Conference Biogen Idec Inc.,
Published by
Business Wire
24 May 13 Biogen Idec Submits Application to FDA for Approval of PLEGRIDY™ (Peginterferon Beta-1a) in Multiple Sclerosis Biogen Idec,
Published by
Business Wire
24 May 13 FDA Accepts Biogen Idec’s Biologics License Application for First Long-Lasting Factor VIII Therapy for Hemophilia A Biogen Idec,
Published by
Business Wire
11 Apr 13 Biogen Idec to Report First Quarter 2013 Financial Results on April 25, 2013 Biogen Idec Inc.,
Published by
Business Wire
Advertising